Shuang Ye

Shanghai Medical College of Fudan University — China

Medicine · Health Sciences

24h-index1.7kcitations80works4.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(31), Endometrial and Cervical Cancer Treatments(10), Intraperitoneal and Appendiceal Malignancies(9), Reproductive System and Pregnancy(8), Cancer Mechanisms and Therapy(7)

Publications80 total

Genetically modified CD19-targeting IL-15 secreting NK cells for the treatment of systemic lupus erythematosus
Annals of the Rheumatic Diseases·2025· 5 cited
Muscle Visualization and Evaluation Methods for Immune Checkpoint Inhibitor-Related Myositis
Journal of Visualized Experiments·2025
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus
The Lancet Rheumatology·2025· 1 cited
The Root Development Genes (RDGs) Network in Brassica napus and the Role of BnaSHR-6 in Response to Low Nitrogen
Plants·2025Open Access
Surufatinib Combined With Toripalimab For The Treatment Of Recurrent Ovarian Clear Cell Carcinoma: Update Of A Prospective Single Center, Single-Arm Phase II Clinical Trial
International Journal of Gynecological Cancer·2025Open Access
Molecular subtype of ovarian clear cell carcinoma: an analysis of 80 Chinese patients using the TCGA molecular classification of endometrial cancer
BMC Cancer·2025· 5 citedOpen Access
Unraveling IFI44L’s biofunction in human disease
Frontiers in Oncology·2024· 8 citedOpen Access
Efficacy and safety of nanoparticle albumin-bound paclitaxel plus carboplatin as neoadjuvant chemotherapy for stages III–IV, unresectable ovarian cancer: a single-arm, open-label, phase Ib/II study
BMC Medicine·2024· 6 citedOpen Access
EV102/#1041  Neoadjuvant adebrelimab plus bevacizumab in locally advanced cervical cancer: an exploratory trial
2024· 1 cited
EV344/#770  Surufatinib combined with toripalimab for the treatment of recurrent ovarian clear cell carcinoma: a prospective single center, single-arm phase II clinical trial
2024
Efficacy and safety of chiauranib in a combination therapy in platinum-resistant or refractory ovarian cancer: a multicenter, open-label, phase Ib and II study
Molecular Cancer·2024· 4 citedOpen Access
Accurate prediction of antibody function and structure using bio-inspired antibody language model
Briefings in Bioinformatics·2024· 24 citedOpen Access
Molecular subtype of ovarian clear cell carcinomas: an analysis of 80 Chinese cases using TCGA molecular classification
2024Open Access
Accurate Prediction of Antibody Function and Structure Using Bio-Inspired Antibody Language Model
2023· 6 citedOpen Access
Genomic profiling of ovarian clear cell carcinoma in Chinese patients reveals potential prognostic biomarkers for survival
Annals of Medicine·2023· 6 citedOpen Access
Comparative genomics reveals the diversification of triterpenoid biosynthesis and origin of ocotillol-type triterpenes in Panax
Plant Communications·2023· 34 citedOpen Access
Comparative Analysis with GC–MS of Fatty Acids and Volatile Compounds of Taraxacum kok-saghyz Rodin and Taraxacum officinale as Edible Resource Plants
Separations·2022· 10 citedOpen Access
Whole-genome resequencing reveals the origin of tea in Lincang
Frontiers in Plant Science·2022· 9 citedOpen Access
The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma
BMC Cancer·2022· 6 citedOpen Access
Peripheral lymphocyte populations in ovarian cancer patients and correlations with clinicopathological features
Journal of Ovarian Research·2022· 16 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Huijuan Yang(18), Libing Xiang(13), Jiaxin Yang(8), Dongyan Cao(8), Keng Shen(7), Xiaohua Wu(7), Yan You(5), Xuan Pei(5), Ming Wu(5), Ling Yang(5), Shuling Zhou(5), Jie Chen(4), Tiancong He(4), Wentao Yang(4), Guanghui Zhang(4), Shengchao Yang(4), Guisheng Xiang(4), Boer Shan(4), Peng Sun(3), Tinghuai Wang(3)